Dhampur Bio Organics Ltd - 543593 - Submission Of Request Letter(S) Received From Promoters Seeking Reclassification From Promoters To Public
Please find attached request letter(s) received from the Promoters seeking Reclassification from Promoters to Public. Dhampur Bio Organics Ltd - 543593 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to MCA General Circular No. 20/2020 dated May 5, 2020 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we enclose herewith copies of Business Standard (English and Hindi Edition) dated June 01, 2023 wherein public notice of 3rd Annual General Meeting of the Company before dispatch of Annual Report for the financial year 2022-23 have been published. Dhampur Bio Organics Ltd - 543593 - Intimation For Adoption Of New Logo
This is to inform that Dhampur Bio Organics Limited has adopted the new logo. Dhampur Bio Organics Ltd - 543593 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Asha Kumari Swarup Dhampur Bio Organics Ltd - 543593 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Asha Kumari Swarup Dhampur Bio Organics Ltd - 543593 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 Dated February 08, 2019, please find enclosed Annual Secretarial Compliance Report for the year ended March 31, 2023 issued by M/s GSK & Associates, Company Secretaries. Dhampur Bio Organics Ltd - 543593 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In compliance with the regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Transcript of Investor Conference Call/ Analyst Meet on Audited Financial Results for the quarter and financial year ended March 31, 2023, held on Thursday, April 27, 2023. Dhampur Bio Organics Ltd - 543593 - Clarification On Revised Audited (Standalone And Consolidated) Financial Results For The Quarter And Year Ended March 31, 2023 Along With The Declaration That Statutory Auditors Have Issued Audit Report With Unmodified Opinion.
This is to inform that the Board of Directors at its meeting held on Tuesday, April 25, 2023 has approved the Audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31, 2023. We would like to inform you that at the time of filing of outcome, the conclusion time of Board Meeting held on April 25, 2023 was inadvertently written as 08:15 p.m. (IST) instead of 09:15 p.m. (IST). A Clarification in respect of the same has already been updated on the exchange(s) on April 25, 2023 itself. Thereafter, in response to the email dated April 28, 2023 received from BSE Limited, we had filed the revised financial results along with a declaration that the statutory auditor has issued audit report with unmodified opinion on April 29, 2023 Further, In response to the email dated May 02, 2023 received from BSE Limited, we confirm that the meeting of the Board was held on Tuesday, April 25, 2023 commenced at 6:45 P.M. (IST) and concluded at 09:15 P.M. (IST). Dhampur Bio Organics Ltd - 543593 - Financial Results For Quarter And Year Ended March 31, 2023
Audited Financial results (Standalone and Consolidated) along with declaration of unmodified opinion for the financial year ended March 31, 2023. Q4FY23 Quarterly & FY23 Annual Result Announced for Dhampur Bio Organics Ltd.
Sugar company Dhampur Bio Organics announced Q4FY23 & FY23 results: Q4FY23: Revenue of the company increased to Rs 917.48 crore in Q4FY23 as against Rs 505.86 crore during Q4FY22 PBT increased to Rs 94.13 crore in Q4FY23 as against Rs 82.80 crore during Q4FY22 PAT increased to Rs 81.95 crore in Q4FY23 as against Rs 69.35 crore during Q4FY22 FY23: EPS stood at Rs 16.87/share for FY23 as against Rs 15.67/share for FY22 The company repaid long term loans of Rs 62.08 crore during FY23 Result PDF